Rubio, Marie Thérèse <br/><br/>
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.  [electronic resource] 

 -  Journal of hematology & oncology  01 2017 
 - 31 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/s13045-016-0389-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antilymphocyte Serum--therapeutic use<br/>Busulfan--therapeutic use<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>HLA Antigens<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Histocompatibility--immunology<br/>Humans<br/>Leukemia, Myeloid, Acute--therapy<br/>Leukocyte Reduction Procedures<br/>Lymphocyte Depletion<br/>Male<br/>Middle Aged<br/>Myeloablative Agonists--therapeutic use<br/>Retrospective Studies<br/>T-Lymphocytes<br/>Transplantation Conditioning--methods<br/>Treatment Outcome<br/>Vidarabine--analogs & derivatives<br/>Young Adult